Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3

Bibliographic Details
Main Authors:	Zhao, Lei, He, Li-Ru, Xi, Mian, Cai, Mu-Yan, Shen, Jing-Xian, Li, Qiao-Qiao, Liao, Yi-Ji, Qian, Dong, Feng, Zi-Zhen, Zeng, Yi-Xin, Xie, Dan, Liu, Meng-Zhong
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540017/

Similar Items

Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma
by: Jin, Ying-Ying, et al.
Published: (2016)

Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma
by: Luo, Li-Ling, et al.
Published: (2015)

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair
by: Liu, Hai, et al.
Published: (2015)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
by: Jiang, Dongxian, et al.
Published: (2015)

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
by: Diaz-Miqueli, Arlhee, et al.
Published: (2013)

EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
by: Perez, Rolando, et al.
Published: (2011)

Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair
by: Qu, Yuan-yuan, et al.
Published: (2013)

Study on chemotherapeutic sensitizing effect of nimotuzumab on different human esophageal squamous carcinoma cells
by: YANG, XIAOYU, et al.
Published: (2016)

Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma
by: Luo, Li-Ling, et al.
Published: (2015)

Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?
by: Zhang, Peng, et al.
Published: (2014)

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
by: Zhang, Peng, et al.
Published: (2014)

MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab
by: Zhang, Kai-Liang, et al.
Published: (2014)

Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial
by: Lu, Ming, et al.
Published: (2016)

Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma
by: Wang, Xi, et al.
Published: (2016)

Nimotuzumab enhances temozolomide‐induced growth suppression of glioma cells expressing mutant EGFR in vivo
by: Nitta, Yusuke, et al.
Published: (2016)

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma
by: Myers, Amy L., et al.
Published: (2015)

A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
by: Shang, Li, et al.
Published: (2014)

Overexpression of Periostin and Lumican in Esophageal Squamous Cell Carcinoma
by: Kashyap, Manoj Kumar, et al.
Published: (2010)

Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone
by: Zhang, Peng, et al.
Published: (2014)

UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo
by: Gao, Xiaojia, et al.
Published: (2016)

O-linked N-acetylglucosamine transferase (OGT) is overexpressed and promotes O-linked protein glycosylation in esophageal squamous cell carcinoma
by: Qiao, Zhe, et al.
Published: (2012)

Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial
by: Liang, Jun, et al.
Published: (2013)

IGFBP2 potentiates nuclear EGFR-STAT3 signaling
by: Chua, Corrine Yingxuan, et al.
Published: (2015)

Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance
by: Jia, Wei, et al.
Published: (2016)

Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma
by: Chen, You-Fang, et al.
Published: (2013)

Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma
by: Zhu, Jinrong, et al.
Published: (2016)

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
by: Michael W. Ronellenfitsch, et al.
Published: (2018-08-01)

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
by: Chong, Dawn Q, et al.
Published: (2015)

Overexpression of OLC1 Promotes Tumorigenesis of Human Esophageal Squamous Cell Carcinoma
by: Li, Xiao, et al.
Published: (2014)

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma
by: Ming-Chun Ma, et al.
Published: (2018-04-01)

Upregulation of SOX4 antagonizes cellular senescence in esophageal squamous cell carcinoma
by: Han, Rongfei, et al.
Published: (2016)

Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
by: Pedicini, Piernicola, et al.
Published: (2012)

Correction: modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
by: Pedicini, Piernicola, et al.
Published: (2012)

Profile of nimotuzumab in the treatment of high-grade glioma
by: Yang, Qun-ying, et al.
Published: (2015)

Therapeutic and Radiosensitizing Effects of Armillaridin on Human Esophageal Cancer Cells
by: Chi, Chih-Wen, et al.
Published: (2013)

Unilateral Cervical Nodal Metastasis Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma Patients Undergoing Chemoradiotherapy: A Retrospective Study
by: Zhang, Peng, et al.
Published: (2014)

Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51
by: Liu, Qiao, et al.
Published: (2011)

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
by: Wang, Chunyu, et al.
Published: (2015)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
by: Zhu, Zhen-Long, et al.
Published: (2013)

Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma
by: Rao, Xuguang, et al.
Published: (2014)